Exploring a New Molecule to Fight Asthma Resistance
Bronchial asthma is often treated with inhaled β2 agonists due to their excellent ability to open up airways. But some people with asthma don't respond well to these treatments. Previous studies found that a certain gene change, called Thr164Ile or T164I, in the β2 adrenergic receptor (β2AR) could b